Yes
Illuccix (tlx591 cdx) is for prostate cancer only as it targets a protein that’s specific to prostate cancer
CAIX is what TLX250cdx is based on for renal
But CAIX is not specific for just renal
They are exploring “CAIX expression in patients with a diverse range of solid tumours – including breast, cervix, colorectal, gastric, esophageal, head and neck, lung, ovarian, pancreatic and vulval cancers2 – for potential diagnostic and therapeutic applications.”
So you could speculate that if it’s injected into a patient with multiple cancer types - then it would look like a star burst I guess which would show the cancer everywhere
So jump on the NCCN website and search the number of people affected by the above per year. Take 5% of those people and multiply it by a $3,000 USD dose for some speculation on a market opportunity
Again, this is my interpretation and I’m not an expert here
- Forums
- ASX - By Stock
- Ann: Phase II study for indication expansion of TLX250-CDx doses
YesIlluccix (tlx591 cdx) is for prostate cancer only as it...
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.55 |
Change
-0.450(2.50%) |
Mkt cap ! $5.872B |
Open | High | Low | Value | Volume |
$17.90 | $17.95 | $17.42 | $21.96M | 1.248M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 17117 | $17.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.57 | 2880 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9791 | 17.540 |
1 | 3048 | 17.510 |
1 | 500 | 17.500 |
1 | 50 | 17.470 |
1 | 20 | 17.460 |
Price($) | Vol. | No. |
---|---|---|
17.570 | 2880 | 1 |
17.600 | 4130 | 2 |
17.620 | 2880 | 1 |
17.650 | 2880 | 2 |
17.660 | 2571 | 1 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online